Pitavastatin — CAS 147526-32-7

Pitavastatin is a synthetic HMG-CoA reductase inhibitor (statin) used for the treatment of hypercholesterolemia and mixed dyslipidemia. It competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis, reducing LDL-C and triglycerides while increasing HDL-C. Mediocon Inc manufactures Pitavastatin API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Treatment of primary hypercholesterolemia and mixed dyslipidemia
• Reduction of LDL cholesterol, total cholesterol, and triglycerides
• Cardiovascular risk reduction in patients with dyslipidemia
• Prevention of atherosclerosis progression

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support